Results 211 to 220 of about 775,328 (297)

Tandem autologous stem cell transplant in multiple myeloma patients with minimal residual disease: an explorative study. [PDF]

Blood Res
Oh S, Park SS, Lee JY, Yoon JH, Lee SE, Kim HJ, Shin SH, Jeon YW, Yahng SA, Jung J, Ahn A, Kim M, Min CK.   +12 more
europepmc   +1 more source

Distinct Clinical Significance of Minimal Residual Disease Detected by 7NB-mRNAs Expression in Bone Marrow at Different Time Points of High-Risk Neuroblastoma Patients. [PDF]

Biology (Basel)
Mon CY, Nay Win KH, Nishimura A, Nakatani N, Tamura A, Yamamoto N, Nino N, Uemura S, Saito A, Ishida T, Mori T, Hasegawa D, Okuno K, Kosaka Y, Ishizawa K, Umemoto M, Matsui T, Nagatani A, Nishimura N.   +18 more
europepmc   +1 more source

Minimal Residual Disease Negativity [PDF]

, 2020
openaire   +1 more source

From residual risk to precision intervention: the evolving role of minimal residual disease in breast cancer management. [PDF]

Cancer Biol Med
Xu J, Fang K, Li X, Han L, Sun S, Sun T.
europepmc   +1 more source

Enhanced AkaLuc Bioluminescence Imaging for Longitudinal Intravital Monitoring of Minimal Residual Disease in a Murine Model of Triple-negative Breast Cancer [PDF]

Silvia Steinbauer, James Cowles, Mohammad A. Sabbaghi, Marle Poppelaars, A. Hussain, Marina Wagesreither, Daniela Laimer-Gruber, József Tóvári, Gergely Szakács, Agnes Csiszar   +9 more
openalex   +1 more source

Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma. [PDF]

Future Oncol
Gordan LN, Warner A, Heritage T, Ming A, Gupta-Werner N, Kaila S, Cortoos A.   +6 more
europepmc   +1 more source

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia

Clinical Medicine Insights: Oncology, 2015
Jitsuda Sitthi-amorn, Betty Herrington, Gail Megason, Jeanette Pullen, Catherine Gordon, Shirley Hogan, Tejaswi Koganti, Chindo Hicks   +7 more
doaj  

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial. [PDF]

ESMO Open
Paracchini L, Velle A, Di Gennaro P, Mannarino L, Ancona L, Lorusso D, Cecere SC, Colombo N, Beltrame L, Fagotti A, Tasca G, Piemontese M, Arenare L, Califano D, Galdiero F, Zadro R, Chiodini P, Perrone F, Biagioli E, D'Incalci M, Romualdi C, Pignata S, Marchini S.   +22 more
europepmc   +1 more source

Minimal Residual Disease Persistence [PDF]

, 2020
openaire   +1 more source